D-0219-2017 Class I Terminated
FDA drug recall D-0219-2017 was initiated by US Compounding Inc on Jul 25, 2016 and is designated Class I. Reason for recall: Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia The recall status is terminated (terminated Apr 6, 2017). Affected quantity: 10,665 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 28, 2016
- Initiation Date
- Jul 25, 2016
- Termination Date
- Apr 6, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,665 syringes
Product Description
Docusate Oral 10 mg/mL Oral Syringe, packaged in a) 1 mL (62295-0601-01), b) 2 mL ( 62295-0601-02), and c) 5 mL syringes (62295-0601-05), US Compounding, Conway, AR
Reason for Recall
Microbial Contamination of Non-Sterile Products; microbial contamination with B. cepacia
Distribution Pattern
TX
Code Information
All Lots
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0219-2017
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026